Vimarsana
Biggest News Aggregation in the World

Barrye Greene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Barrye Greene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Barrye Greene Today - Breaking & Trending Today

Karyopharm Therapeutics : April 11, 2023 - Vimarsana News

Karyopharm Therapeutics : April 11, 2023

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON WEDNESDAY, MAY 24, 2023 Dear Stockholder: You are cordially invited to our 2023... | April 11, 2023

Karyopharm Announces the Appointment of Peter K Honig, MD, MPH to its Board of Directors - Vimarsana News

Karyopharm Announces the Appointment of Peter K Honig, MD, MPH to its Board of Directors

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the...

Karyopharm Announces the Appointment of Peter K Honig, MD, MPH to its Board of Directors - Vimarsana News

Karyopharm Announces the Appointment of Peter K Honig, MD, MPH to its Board of Directors

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the...

Sage Therapeutics Announces the Appointment of Barry Greene as CEO - Vimarsana News

Sage Therapeutics Announces the Appointment of Barry Greene as CEO

Published: Dec 16, 2020   Barry Greene, a world-class leader with global experience and a significant track record of success in R&D and commercialization, joins as part of plan to accelerate the Sage mission to deliver truly transformational medicines for people with brain health disorders Jeff Jonas to assume new role of Chief Innovation Officer, Chair of the Science and Technology Forum, remaining a member of the Board and bolstering plans for further expansion of pipeline opportunities   CAMBRIDGE, Mass.--(BUSINESS WIRE)-- SAGE Therapeutics (NASDAQ: SAGE), a biopharmaceutical compan...